CN105037369B - A kind of synthetic method of pyrazolo [5,1 a] Carbox amide of iso-indoles 3 - Google Patents
A kind of synthetic method of pyrazolo [5,1 a] Carbox amide of iso-indoles 3 Download PDFInfo
- Publication number
- CN105037369B CN105037369B CN201510345086.6A CN201510345086A CN105037369B CN 105037369 B CN105037369 B CN 105037369B CN 201510345086 A CN201510345086 A CN 201510345086A CN 105037369 B CN105037369 B CN 105037369B
- Authority
- CN
- China
- Prior art keywords
- mmol
- phenyl
- ethyl acetate
- pyrazolo
- acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000010189 synthetic method Methods 0.000 title claims description 8
- 150000002518 isoindoles Chemical class 0.000 title claims 3
- 125000003917 carbamoyl group Chemical class [H]N([H])C(*)=O 0.000 title 1
- 238000006243 chemical reaction Methods 0.000 claims abstract description 39
- 239000012298 atmosphere Substances 0.000 claims abstract description 32
- -1 transition metal salt Chemical class 0.000 claims abstract description 21
- 239000007800 oxidant agent Substances 0.000 claims abstract description 5
- 239000002904 solvent Substances 0.000 claims abstract description 5
- 229910052723 transition metal Inorganic materials 0.000 claims abstract description 5
- 239000003054 catalyst Substances 0.000 claims abstract description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 58
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 29
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 claims description 24
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical group [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 5
- 239000002585 base Substances 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- 229910052763 palladium Inorganic materials 0.000 claims description 5
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 239000011737 fluorine Substances 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 150000002527 isonitriles Chemical class 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 3
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 3
- 230000001590 oxidative effect Effects 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 claims description 3
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 claims description 3
- 229940071536 silver acetate Drugs 0.000 claims description 3
- 229910001958 silver carbonate Inorganic materials 0.000 claims description 3
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims 2
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 claims 2
- 150000002431 hydrogen Chemical group 0.000 claims 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N vinyl-ethylene Natural products C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 claims 2
- 125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 150000001336 alkenes Chemical class 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 25
- YLIJODVKDABYOC-UHFFFAOYSA-N 3H-pyrazolo[5,1-a]isoindole-1-carboxamide Chemical class N1C=C(C=2N1C=C1C=CC=CC=21)C(=O)N YLIJODVKDABYOC-UHFFFAOYSA-N 0.000 abstract description 8
- 238000003786 synthesis reaction Methods 0.000 abstract description 8
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 5
- 238000005580 one pot reaction Methods 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- FUNGOSASHDEMLD-UHFFFAOYSA-N 1-(2-bromophenyl)buta-2,3-dien-1-one Chemical compound BrC1=CC=CC=C1C(=O)C=C=C FUNGOSASHDEMLD-UHFFFAOYSA-N 0.000 abstract description 3
- 238000000746 purification Methods 0.000 abstract description 3
- 239000000758 substrate Substances 0.000 abstract description 3
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 239000000543 intermediate Substances 0.000 abstract description 2
- 230000002194 synthesizing effect Effects 0.000 abstract description 2
- 239000002699 waste material Substances 0.000 abstract description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 174
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 84
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 58
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 39
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 29
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 29
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 29
- 239000000203 mixture Substances 0.000 description 29
- 239000012074 organic phase Substances 0.000 description 29
- 239000003208 petroleum Substances 0.000 description 29
- 239000000741 silica gel Substances 0.000 description 29
- 229910002027 silica gel Inorganic materials 0.000 description 29
- 239000000243 solution Substances 0.000 description 29
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 28
- 238000003756 stirring Methods 0.000 description 28
- FAGLEPBREOXSAC-UHFFFAOYSA-N tert-butyl isocyanide Chemical compound CC(C)(C)[N+]#[C-] FAGLEPBREOXSAC-UHFFFAOYSA-N 0.000 description 28
- 239000000047 product Substances 0.000 description 27
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical group [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 26
- 239000007787 solid Substances 0.000 description 26
- 229910052938 sodium sulfate Inorganic materials 0.000 description 12
- 235000011152 sodium sulphate Nutrition 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- 238000012512 characterization method Methods 0.000 description 10
- 238000000926 separation method Methods 0.000 description 9
- 238000001035 drying Methods 0.000 description 8
- 238000001914 filtration Methods 0.000 description 8
- ZVXKYWHJBYIYNI-UHFFFAOYSA-N 1h-pyrazole-4-carboxamide Chemical compound NC(=O)C=1C=NNC=1 ZVXKYWHJBYIYNI-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- VSTXCZGEEVFJES-UHFFFAOYSA-N 1-cycloundecyl-1,5-diazacycloundec-5-ene Chemical compound C1CCCCCC(CCCC1)N1CCCCCC=NCCC1 VSTXCZGEEVFJES-UHFFFAOYSA-N 0.000 description 2
- IMBBXSASDSZJSX-UHFFFAOYSA-N 4-Carboxypyrazole Chemical compound OC(=O)C=1C=NNC=1 IMBBXSASDSZJSX-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 239000007832 Na2SO4 Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 1
- PLLYMWWNLWOPEG-UHFFFAOYSA-N 1,3-dihydropyrazole-2-carbaldehyde Chemical compound C(=O)N1NC=CC1 PLLYMWWNLWOPEG-UHFFFAOYSA-N 0.000 description 1
- IBXMKLPFLZYRQZ-UHFFFAOYSA-N 1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1 IBXMKLPFLZYRQZ-UHFFFAOYSA-N 0.000 description 1
- DNJLFZHMJDSJFN-UHFFFAOYSA-N 2-isocyano-1,3-dimethylbenzene Chemical compound CC1=CC=CC(C)=C1[N+]#[C-] DNJLFZHMJDSJFN-UHFFFAOYSA-N 0.000 description 1
- IUZRIMBZWIJCGN-UHFFFAOYSA-N 3H-pyrazolo[5,1-a]isoindole Chemical compound N1C=CC=2N1C=C1C=CC=CC=21 IUZRIMBZWIJCGN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- JQGPBDSMTHZOMO-UHFFFAOYSA-N OBO.C=1C=NNC=1 Chemical compound OBO.C=1C=NNC=1 JQGPBDSMTHZOMO-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000006069 Suzuki reaction reaction Methods 0.000 description 1
- 238000007239 Wittig reaction Methods 0.000 description 1
- OFLXLNCGODUUOT-UHFFFAOYSA-N acetohydrazide Chemical compound C\C(O)=N\N OFLXLNCGODUUOT-UHFFFAOYSA-N 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000005915 ammonolysis reaction Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- RROBIDXNTUAHFW-UHFFFAOYSA-N benzotriazol-1-yloxy-tris(dimethylamino)phosphanium Chemical compound C1=CC=C2N(O[P+](N(C)C)(N(C)C)N(C)C)N=NC2=C1 RROBIDXNTUAHFW-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000006361 intramolecular Friedel-Crafts acylation reaction Methods 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 238000007040 multi-step synthesis reaction Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 150000003217 pyrazoles Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
Abstract
本发明公开了一种吡唑并[5,1‑a]异吲哚‑3‑甲酰胺类化合物的合成方法,属于有机合成技术领域。本发明的技术方案要点为:将1‑(2‑溴苯基)‑2,3‑丁二烯‑1‑酮或其衍生物和酰肼溶于溶剂中,室温反应1小时后加入异腈、催化剂过渡金属盐、氧化剂和碱,然后在空气气氛中于80‑140℃反应制得吡唑并[5,1‑a]异吲哚‑3‑甲酰胺类化合物。本发明合成过程为一锅多步串联反应,避免了现有方法因中间体的纯化处理等引起的资源浪费和环境污染,合成过程中使用的原料价廉易得或易于制备,反应操作简便,底物的适用范围广。The invention discloses a method for synthesizing pyrazolo[5,1- a ]isoindole-3-carboxamide compounds, belonging to the technical field of organic synthesis. The main points of the technical scheme of the present invention are: dissolving 1-(2-bromophenyl)-2,3-butadiene-1-one or its derivatives and hydrazide in a solvent, adding isocyanide after reacting at room temperature for 1 hour , a catalyst transition metal salt, an oxidizing agent and a base, and then react in an air atmosphere at 80-140°C to prepare pyrazolo[5,1- a ]isoindole-3-carboxamide compounds. The synthesis process of the present invention is a one-pot multi-step series reaction, which avoids the waste of resources and environmental pollution caused by the purification treatment of intermediates in the existing method, the raw materials used in the synthesis process are cheap and easy to obtain or easy to prepare, and the reaction operation is simple and convenient. The scope of application of the substrate is wide.
Description
技术领域technical field
本发明属于有机合成技术领域,具体涉及一种吡唑并[5,1-a]异吲哚-3-甲酰胺类化合物的合成方法。The invention belongs to the technical field of organic synthesis, and in particular relates to a synthesis method of pyrazolo[5,1- a ]isoindole-3-carboxamide compounds.
背景技术Background technique
稠合吡唑结构单元在天然产物中广泛存在,许多稠合吡唑衍生物还显示出良好的生物活性,多年来一直受到化学家及药物学家的关注。其中,吡唑并[5,1-a]异吲哚具有调节植物生长、降压、抗菌及抗抑郁等活性,在相关的药物开发方面具有广阔的应用前景。目前,该类化合物的合成方法主要包括磷叶立德的分子内Wittig反应、吡唑硼酸酯的Suzuki偶联以及N-甲酰基吡唑啉的分子内Friedel-Crafts酰基化等。这些文献方法大都需要经过多步骤合成及繁琐的分离纯化过程,所用原料难以制得,反应条件苛刻,从而使其在实际生产中的应用受到限制。另一方面,吡唑-4-甲酰胺是药物化学研究中的优势结构单元,许多临床药物及先导化合物中均含有这一结构骨架。现有合成吡唑-4-甲酰胺的方法主要是通过吡唑-4-甲酸与胺在苯并三氮唑-1-基氧基三(二甲基氨基)磷鎓六氟磷酸盐(BOP试剂)的活化作用下发生氨解、或以固载的吡唑-4-羧酸衍生物为原料经多步固相合成法制得。这些合成方法尚存在反应步骤多、试剂昂贵、原子经济差等问题。有鉴于此,开发含有吡唑-4-甲酰胺结构单元的吡唑并[5,1-a]异吲哚-3-甲酰胺类化合物的简捷、高效合成新方法,在有机合成化学及药物化学等研究领域具有重要的意义。Fused pyrazole structural units widely exist in natural products, and many fused pyrazole derivatives also show good biological activities, which have attracted the attention of chemists and pharmacologists for many years. Among them, pyrazolo[5,1- a ]isoindole has activities such as regulating plant growth, reducing blood pressure, antibacterial and antidepressant, and has broad application prospects in the development of related drugs. At present, the synthesis methods of this kind of compounds mainly include the intramolecular Wittig reaction of phosphorus ylides, the Suzuki coupling of pyrazole boronate, and the intramolecular Friedel-Crafts acylation of N -formyl pyrazoline, etc. Most of these literature methods require multi-step synthesis and tedious separation and purification process, the raw materials used are difficult to obtain, and the reaction conditions are harsh, which limits their application in actual production. On the other hand, pyrazole-4-carboxamide is an advantageous structural unit in medicinal chemistry research, and many clinical drugs and lead compounds contain this structural skeleton. The existing method of synthesizing pyrazole-4-carboxamide is mainly through pyrazole-4-formic acid and amine in benzotriazol-1-yloxy tris(dimethylamino)phosphonium hexafluorophosphate (BOP Reagent) is activated by ammonolysis, or it is prepared by multi-step solid-phase synthesis using immobilized pyrazole-4-carboxylic acid derivatives as raw materials. These synthetic methods still have problems such as many reaction steps, expensive reagents, and poor atom economy. In view of this, the development of a simple and efficient new method for the synthesis of pyrazolo[5,1- a ]isoindole-3-carboxamides containing pyrazole-4-carboxamide structural units has great potential in organic synthetic chemistry and pharmaceuticals. Research fields such as chemistry are of great significance.
发明内容Contents of the invention
本发明解决的技术问题是提供了一种吡唑并[5,1-a]异吲哚-3-甲酰胺类化合物的合成方法,该合成方法从商品化试剂或简单易制备的原料出发,通过一锅多步串联反应,直接得到吡唑并[5,1-a]异吲哚-3-甲酰胺类化合物,即在一锅反应中同时构筑出吡唑环和异吲哚环,并且在吡唑环的4-位引入甲酰胺结构单元,操作方便,原子经济性好,底物适用范围广,适合于工业化生产。The technical problem solved by the present invention is to provide a synthetic method of pyrazolo[5,1- a ]isoindole-3-carboxamides, the synthetic method starts from commercial reagents or simple and easy-to-prepare raw materials, Through a one-pot multi-step series reaction, the pyrazolo[5,1- a ]isoindole-3-carboxamide compound is directly obtained, that is, the pyrazole ring and the isoindole ring are simultaneously constructed in the one-pot reaction, and The formamide structural unit is introduced into the 4-position of the pyrazole ring, the operation is convenient, the atom economy is good, the substrate has a wide application range, and is suitable for industrial production.
本发明为解决上述技术问题采用如下技术方案,一种吡唑并[5,1-a]异吲哚-3-甲酰胺类化合物的合成方法,其特征在于:将1-(2-溴苯基)-2,3-丁二烯-1-酮或其衍生物和酰肼溶于溶剂中,室温反应1小时后加入异腈、催化剂过渡金属盐、氧化剂和碱,然后在空气气氛中于80-140℃反应制得吡唑并[5,1-a]异吲哚-3-甲酰胺类化合物,该合成方法中的反应方程式为:In order to solve the above-mentioned technical problems, the present invention adopts the following technical scheme, a synthetic method of pyrazolo[5,1- a ]isoindole-3-carboxamides, which is characterized in that: 1-(2-bromobenzene Base)-2,3-butadien-1-one or its derivatives and hydrazide are dissolved in a solvent, react at room temperature for 1 hour, add isonitrile, catalyst transition metal salt, oxidizing agent and base, and then in air atmosphere React at 80-140°C to prepare pyrazolo[5,1- a ]isoindole-3-carboxamides. The reaction equation in this synthesis method is:
其中R1为氢、氟、氯、三氟甲基、甲基或烷氧基,R2为氢、烷基、苯基或取代苯基,R3为烷基、苯基或取代苯基,R4为烷基、苯基或取代苯基,上述取代苯基苯环上的取代基分别为氟、氯、溴、甲基、三氟甲基或甲氧基中的一种或多种,取代基的位置为苯环上的邻位、间位或对位,溶剂为N,N-二甲基甲酰胺、1,4-二氧六环或甲苯,催化剂过渡金属盐为醋酸钯、氯化钯、二(三苯基膦)二氯化钯、三(二亚苄基丙酮)二钯或四(三苯基膦)钯,氧化剂为氧气、醋酸银、碳酸银或醋酸铜,碱为碳酸钾、三乙胺、1,8-二氮杂二环十一碳-7-烯、碳酸钠、碳酸铯或氢氧化钾。 Wherein R is hydrogen, fluorine, chlorine, trifluoromethyl, methyl or alkoxy, R is hydrogen , alkyl, phenyl or substituted phenyl, R is alkyl, phenyl or substituted phenyl, R is alkyl, phenyl or substituted phenyl, and the substituents on the above-mentioned substituted phenyl benzene ring are respectively one or more of fluorine, chlorine, bromine, methyl, trifluoromethyl or methoxy, The position of the substituent is the ortho, meta or para position on the benzene ring, the solvent is N,N-dimethylformamide, 1,4-dioxane or toluene, the catalyst transition metal salt is palladium acetate, chlorine Palladium chloride, bis(triphenylphosphine)palladium dichloride, tris(dibenzylideneacetone)dipalladium or tetrakis(triphenylphosphine)palladium, the oxidant is oxygen, silver acetate, silver carbonate or copper acetate, the base is Potassium carbonate, triethylamine, 1,8-diazabicycloundec-7-ene, sodium carbonate, cesium carbonate, or potassium hydroxide.
进一步限定,所述的1-(2-溴苯基)-2,3-丁二烯-1-酮或其衍生物、酰肼和异腈的投料物质的量之比为1:1-1.5:2-4。It is further defined that the ratio of the amount of the 1-(2-bromophenyl)-2,3-butadien-1-one or its derivatives, hydrazide and isonitrile is 1:1-1.5 :2-4.
本发明与现有技术相比具有以下优点:(1)合成过程为一锅多步串联反应,避免了现有方法因中间体的纯化处理等引起的资源浪费和环境污染;(2)合成过程中使用的原料价廉易得或易于制备;(3)反应操作简便;(4)底物的适用范围广。因此,本发明为吡唑并[5,1-a]异吲哚-3-甲酰胺类化合物的合成提供了一种经济实用且高效的新方法。Compared with the prior art, the present invention has the following advantages: (1) the synthesis process is a one-pot multi-step series reaction, which avoids resource waste and environmental pollution caused by the purification of intermediates in the existing method; (2) the synthesis process The raw materials used in the method are cheap and easy to obtain or easy to prepare; (3) the reaction operation is simple; (4) the substrate has a wide range of applications. Therefore, the present invention provides an economical, practical and efficient new method for the synthesis of pyrazolo[5,1- a ]isoindole-3-carboxamide compounds.
具体实施方式detailed description
以下通过实施例对本发明的上述内容做进一步详细说明,但不应该将此理解为本发明上述主题的范围仅限于以下的实施例,凡基于本发明上述内容实现的技术均属于本发明的范围。The above-mentioned contents of the present invention are described in further detail below through the embodiments, but this should not be interpreted as the scope of the above-mentioned themes of the present invention being limited to the following embodiments, and all technologies realized based on the above-mentioned contents of the present invention all belong to the scope of the present invention.
实施例1Example 1
在25 mL反应瓶中加入1-(2-溴苯基)-2,3-丁二烯-1-酮(1a, 0.2 mmol, 44.4mg)、乙酰肼(2a,0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入醋酸钯(0.01 mmol, 2.2 mg)、醋酸铜(0.2 mmol, 36.2 mg)、叔丁基异腈(3a, 0.44mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(55 mg, 82%)。该化合物的表征数据如下:1H NMR (400MHz, CDCl3) δ: 1.50 (s, 9H), 1.60 (s, 9H), 2.50 (s, 3H), 5.69 (s, 1H), 7.36(t, J = 7.6 Hz, 1H), 7.44-7.48 (m, 1H), 7.76 (d, J = 7.2 Hz, 1H), 8.04 (d, J= 7.2 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ: 14.7, 29.0, 29.1, 51.8, 55.6,111.3, 118.3, 122.5, 123.7, 129.3, 131.3, 136.9, 152.8, 157.3, 162.7. HRMScalcd for C20H27N4O: 339.2179 [M+H]+, found: 339.2189。Add 1-(2-bromophenyl)-2,3-butadien-1-one (1a, 0.2 mmol, 44.4 mg), acetylhydrazide (2a, 0.22 mmol, 16.3 mg) and N,N-Dimethylformamide (1 mL), stirred at room temperature for 1 hour, then added palladium acetate (0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol , 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg). The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine, Dry over anhydrous sodium sulfate. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4a (55 mg, 82%) as a white solid. The characterization data of this compound are as follows: 1 H NMR (400MHz, CDCl 3 ) δ: 1.50 (s, 9H), 1.60 (s, 9H), 2.50 (s, 3H), 5.69 (s, 1H), 7.36(t, 13 C NMR ( 100 MHz , CDCl 3 ) δ: 14.7, 29.0, 29.1, 51.8, 55.6, 111.3, 118.3, 122.5, 123.7, 129.3, 131.3 , 136.9 , 152.8 , 157.3, 162.7 . , found: 339.2189.
实施例2Example 2
在25 mL反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.4 mmol, 29.6 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入醋酸钯(0.01 mmol, 2.2 mg)、醋酸铜(0.2mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(51 mg, 75%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.4 mmol, 29.6 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction flask, stir at room temperature for 1 hour, then add palladium acetate ( 0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg). The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine, Dry over anhydrous sodium sulfate. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4a (51 mg, 75%) as a white solid.
实施例3Example 3
在25 mL反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入醋酸钯(0.01 mmol, 2.2 mg)、醋酸铜(0.2mmol, 36.2 mg)、叔丁基异腈(3a, 0.8 mmol, 66.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(54 mg, 80%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction flask, stir at room temperature for 1 hour, then add palladium acetate ( 0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.8 mmol, 66.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg). The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine, Dry over anhydrous sodium sulfate. After filtration, spin-drying, and silica gel column separation (petroleum ether/ethyl acetate=20/1), the product 4a (54 mg, 80%) was obtained as a white solid.
实施例4Example 4
在25 mL反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入醋酸钯(0.01 mmol, 2.2 mg)、醋酸铜(0.2mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和1,8-二氮杂二环十一碳-7-烯(0.4 mmol, 60.8 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(42 mg, 62%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction flask, stir at room temperature for 1 hour, then add palladium acetate ( 0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and 1,8-diazabicycloundec-7-ene (0.4 mmol, 60.8 mg). The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine, Dry over anhydrous sodium sulfate. After filtration, spin-drying, and silica gel column separation (petroleum ether/ethyl acetate=20/1), the product 4a (42 mg, 62%) was obtained as a white solid.
实施例5Example 5
在25 mL反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入醋酸钯(0.01 mmol, 2.2 mg)、醋酸铜(0.2mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸铯(0.4 mmol, 130.3mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(51 mg,75%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction flask, stir at room temperature for 1 hour, then add palladium acetate ( 0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and cesium carbonate (0.4 mmol, 130.3 mg). The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine, Dry over anhydrous sodium sulfate. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4a (51 mg, 75%) as a white solid.
实施例6Example 6
在25 mL的反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入氯化钯(0.01 mmol, 1.8 mg)、四氟硼酸三叔丁基膦(0.02 mmol, 5.8 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(28 mg, 42%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction flask, stir at room temperature for 1 hour, then add chloride Palladium (0.01 mmol, 1.8 mg), tri-tert-butylphosphine tetrafluoroborate (0.02 mmol, 5.8 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg). The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine, Dry over anhydrous sodium sulfate. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4a (28 mg, 42%) as a white solid.
实施例7Example 7
在25 mL的反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入二(三苯基膦)二氯化钯(0.01 mmol,7.0 mg)、四氟硼酸三叔丁基膦(0.02 mmol, 5.8 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(20 mg, 30%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction flask, stir at room temperature for 1 hour, then add di( triphenylphosphine) palladium dichloride (0.01 mmol, 7.0 mg), tri-tert-butylphosphine tetrafluoroborate (0.02 mmol, 5.8 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg). The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine, Dry over anhydrous sodium sulfate. Filtration, spin-drying, and silica gel column separation (petroleum ether/ethyl acetate=20/1) gave the product 4a (20 mg, 30%) as a white solid.
实施例8Example 8
在25 mL的反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入三(二亚苄基丙酮)二钯(0.01 mmol,9.2 mg)、四氟硼酸三叔丁基膦(0.02 mmol, 5.8 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(22 mg, 32%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction flask, stir at room temperature for 1 hour, and then add tri( Dibenzylideneacetone) dipalladium (0.01 mmol, 9.2 mg), tri-tert-butylphosphine tetrafluoroborate (0.02 mmol, 5.8 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol , 55.2 mg). The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine, Dry over anhydrous sodium sulfate. Filtration, spin-drying, and silica gel column separation (petroleum ether/ethyl acetate=20/1) gave the product 4a (22 mg, 32%) as a white solid.
实施例9Example 9
在25 mL的反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入四(三苯基膦)钯(0.01 mmol, 11.6mg)、四氟硼酸三叔丁基膦(0.02 mmol, 5.8 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),合并有机相,用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(17 mg, 25%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction vial, stir at room temperature for 1 hour, then add four ( triphenylphosphine) palladium (0.01 mmol, 11.6 mg), tri-tert-butylphosphine tetrafluoroborate (0.02 mmol, 5.8 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg). The resulting mixture was stirred and reacted at 120°C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), combined the organic phases, and washed with water and saturated brine successively , dried over anhydrous sodium sulfate. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4a (17 mg, 25%) as a white solid.
实施例10Example 10
在25 mL的反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入醋酸钯(0.01 mmol, 2.2 mg)、四氟硼酸三叔丁基膦(0.02 mmol, 5.8 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4mmol, 55.2 mg)。所得混合物在氧气气氛及120℃的温度条件下搅拌反应8小时后,加入10mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),合并有机相并用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(31 mg, 46%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction flask, stir at room temperature for 1 hour, then add palladium acetate (0.01 mmol, 2.2 mg), tri-tert-butylphosphine tetrafluoroborate (0.02 mmol, 5.8 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg). The resulting mixture was stirred and reacted under an oxygen atmosphere and a temperature of 120 °C for 8 hours, and then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), combined the organic phases with water and saturated saline Washed successively and dried over anhydrous sodium sulfate. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4a (31 mg, 46%) as a white solid.
实施例11Example 11
在25 mL的反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入醋酸钯(0.01 mmol, 2.2 mg)、四氟硼酸三叔丁基膦(0.02 mmol, 5.8 mg)、醋酸银(0.2 mmol, 33.4 mg)、叔丁基异腈(3a, 0.44mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(39 mg, 58%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction flask, stir at room temperature for 1 hour, then add palladium acetate (0.01 mmol, 2.2 mg), tri-tert-butylphosphine tetrafluoroborate (0.02 mmol, 5.8 mg), silver acetate (0.2 mmol, 33.4 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate ( 0.4 mmol, 55.2 mg). The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine, Dry over anhydrous sodium sulfate. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4a (39 mg, 58%) as a white solid.
实施例12Example 12
在25 mL的反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入醋酸钯(0.01 mmol, 2.2 mg)、四氟硼酸三叔丁基膦(0.02 mmol, 5.8 mg)、碳酸银(0.2 mmol, 55.2 mg)、叔丁基异腈(3a, 0.44mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(35 mg, 52%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction flask, stir at room temperature for 1 hour, then add palladium acetate (0.01 mmol, 2.2 mg), tri-tert-butylphosphine tetrafluoroborate (0.02 mmol, 5.8 mg), silver carbonate (0.2 mmol, 55.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate ( 0.4 mmol, 55.2 mg). The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed with water and saturated brine in sequence, Dry over anhydrous sodium sulfate. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4a (35 mg, 52%) as a white solid.
实施例13Example 13
在25 mL的反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入醋酸钯(0.01 mmol, 2.2 mg)、四氟硼酸三叔丁基膦(0.02 mmol, 5.8 mg)、醋酸铜(0.2 mmol, 36.3 mg)、叔丁基异腈(3a, 0.44mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(49 mg, 72%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction flask, stir at room temperature for 1 hour, then add palladium acetate (0.01 mmol, 2.2 mg), tri-tert-butylphosphine tetrafluoroborate (0.02 mmol, 5.8 mg), copper acetate (0.2 mmol, 36.3 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate ( 0.4 mmol, 55.2 mg). The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine, Dry over anhydrous sodium sulfate. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4a (49 mg, 72%) as a white solid.
实施例14Example 14
在25 mL的反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入醋酸钯(0.01 mmol, 2.2 mg)、醋酸铜(0.2 mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2mg)。所得混合物在空气气氛中于140℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(49 mg,72%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction flask, stir at room temperature for 1 hour, then add palladium acetate (0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg). The resulting mixture was stirred and reacted at 140 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed with water and saturated brine in sequence, Dry over anhydrous sodium sulfate. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4a (49 mg, 72%) as a white solid.
实施例15Example 15
在25 mL的反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入醋酸钯(0.01 mmol, 2.2 mg)、醋酸铜(0.2 mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2mg)。所得混合物在空气气氛中于100℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(42 mg,62%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction flask, stir at room temperature for 1 hour, then add palladium acetate (0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg). The resulting mixture was stirred and reacted at 100 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine, Dry over anhydrous sodium sulfate. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4a (42 mg, 62%) as a white solid.
实施例16Example 16
在25 mL的反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.22 mmol, 16.3 mg)及1,4-二氧六环(1 mL),室温搅拌1小时后,再加入醋酸钯(0.01 mmol, 2.2 mg)、醋酸铜(0.2mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中回流搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(38 mg, 56%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.22 mmol, 16.3 mg) and 1,4-dioxane (1 mL) into a 25 mL reaction flask, stir at room temperature for 1 hour, then add palladium acetate ( 0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg). The resulting mixture was refluxed and stirred for 8 hours in an air atmosphere, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine, and anhydrous Na2SO4 dried. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4a (38 mg, 56%) as a white solid.
实施例17Example 17
在25 mL的反应瓶中加入1a(0.2 mmol, 44.4 mg)、2a(0.22 mmol, 16.3 mg)及甲苯(1 mL),室温搅拌1小时后,再加入醋酸钯(0.01 mmol, 2.2 mg)、醋酸铜(0.2 mmol,36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中回流搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(35 mg, 52%)。Add 1a (0.2 mmol, 44.4 mg), 2a (0.22 mmol, 16.3 mg) and toluene (1 mL) into a 25 mL reaction flask, stir at room temperature for 1 hour, then add palladium acetate (0.01 mmol, 2.2 mg), Copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg). The resulting mixture was refluxed and stirred for 8 hours in an air atmosphere, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine, and anhydrous Na2SO4 dried. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4a (35 mg, 52%) as a white solid.
实施例18Example 18
按实施例1所述的方法,在25 mL的反应瓶中加入1a (0.2 mmol, 44.4 mg)、2b(0.22 mmol, 30.0 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,再加入醋酸钯(0.01 mmol, 2.2 mg)、醋酸铜(0.2 mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(35 mg, 52%)。According to the method described in Example 1, 1a (0.2 mmol, 44.4 mg), 2b (0.22 mmol, 30.0 mg) and N,N-dimethylformamide (1 mL) were added to a 25 mL reaction vial, at room temperature After stirring for 1 hour, additional palladium acetate (0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg) were added. The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed with water and saturated brine in sequence, Dry over anhydrous sodium sulfate. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4a (35 mg, 52%) as a white solid.
实施例19Example 19
按实施例1所述的方法,在25 mL的反应瓶中加入1a (0.2 mmol, 44.4 mg)、2c(0.22 mmol, 36.5 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时,再加入醋酸钯(0.01mmol, 2.2 mg)、醋酸铜(0.2 mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4a(30 mg, 45%)。According to the method described in Example 1, 1a (0.2 mmol, 44.4 mg), 2c (0.22 mmol, 36.5 mg) and N,N-dimethylformamide (1 mL) were added to a 25 mL reaction vial, at room temperature After stirring for 1 hour, palladium acetate (0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg) were added. The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine. water and sodium sulfate to dry. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4a (30 mg, 45%) as a white solid.
实施例20Example 20
按实施例1所述的方法,在25 mL的反应瓶中加入1b (0.2 mmol, 47.2 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时,加入醋酸钯(0.01mmol, 2.2 mg)、醋酸铜(0.2 mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4b(61 mg, 86%)。该化合物的表征数据如下:1H NMR (400 MHz, CDCl3) δ: 1.50(s, 9H), 1.60 (s, 9H), 2.40 (s, 3H), 2.49 (s, 3H), 5.67 (s, 1H), 7.25 (d, J =6.0 Hz, 1H), 7.58 (s, 1H), 7.90 (d, J = 7.6 Hz, 1H). 13C NMR (100 MHz, CDCl3)δ: 14.6, 21.6, 28.9, 29.1, 51.7, 55.5, 111.8, 117.9, 122.2, 124.3, 126.7,131.9, 138.1, 139.7, 148.5, 152.8, 162.8. HRMS calcd for C21H29N4O: 353.2336 [M+H]+, found: 353.2347。According to the method described in Example 1, 1b (0.2 mmol, 47.2 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) were added to a 25 mL reaction vial, at room temperature After stirring for 1 hour, palladium acetate (0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg) were added. The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine. water and sodium sulfate to dry. After filtration, spin-drying, and silica gel column separation (petroleum ether/ethyl acetate=20/1), the product 4b (61 mg, 86%) was obtained as a white solid. The characterization data of this compound are as follows: 1 H NMR (400 MHz, CDCl 3 ) δ: 1.50(s, 9H), 1.60 (s, 9H), 2.40 (s, 3H), 2.49 (s, 3H), 5.67 (s , 1H), 7.25 (d, J =6.0 Hz, 1H), 7.58 (s, 1H), 7.90 (d, J = 7.6 Hz, 1H). 13 C NMR (100 MHz, CDCl 3 )δ: 14.6, 21.6 , 28.9, 29.1, 51.7, 55.5, 111.8, 117.9, 122.2, 124.3, 126.7,131.9, 138.1, 139.7, 148.5, 152.8, 162.8. HRMS calcd for C 21 H + 29 N 4 O: 363 [ found: 353.2347.
实施例21Example 21
按实施例1所述的方法,在25 mL的反应瓶中加入1c (0.2 mmol, 50.4 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时,加入醋酸钯(0.01mmol, 2.2 mg)、醋酸铜(0.2 mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4c(66 mg, 89%)。该化合物的表征数据如下:1H NMR (400 MHz, CDCl3) δ: 1.50(s, 9H), 1.59 (s, 9H), 2.49 (s, 3H), 3.89 (s, 3H), 5.67 (s, 1H), 6.85 (d, J =9.2 Hz, 1H), 7.58 (s, 1H), 7.66 (d, J = 8.0 Hz, 1H). 13C NMR (100 MHz, CDCl3)δ: 14.5, 29.0, 29.1, 51.7, 55.4, 55.7, 107.9, 111.6, 114.6, 125.0, 129.1,130.8, 137.5, 147.6, 152.6, 162.4, 162.7. HRMS calcd for C21H29N4O2: 369.2285[M+H]+, found: 369.2296。According to the method described in Example 1, 1c (0.2 mmol, 50.4 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) were added to a 25 mL reaction vial, at room temperature After stirring for 1 hour, palladium acetate (0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg) were added. The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine. water and sodium sulfate to dry. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4c (66 mg, 89%) as a white solid. The characterization data of this compound are as follows: 1 H NMR (400 MHz, CDCl 3 ) δ: 1.50(s, 9H), 1.59 (s, 9H), 2.49 (s, 3H), 3.89 (s, 3H), 5.67 (s , 1H), 6.85 (d, J =9.2 Hz, 1H), 7.58 (s, 1H), 7.66 (d, J = 8.0 Hz, 1H). 13 C NMR (100 MHz, CDCl 3 )δ: 14.5, 29.0 , 29.1, 51.7, 55.4, 55.7, 107.9, 111.6, 114.6, 125.0 , 129.1,130.8 , 137.5, 147.6 , 152.6, 162.4, 162.7 . , found: 369.2296.
实施例22Example 22
按实施例1所述的方法,在25 mL的反应瓶中加入1d (0.2 mmol, 48.0 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时,加入醋酸钯(0.01mmol, 2.2 mg)、醋酸铜(0.2 mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4d(51 mg, 72%)。该化合物的表征数据如下:1H NMR (400 MHz, CDCl3) δ: 1.49(s, 9H), 1.58 (s, 9H), 2.50 (s, 3H), 5.67 (s, 1H), 7.11-7.15 (m, 1H), 7.44(dd, J 1 = 7.6 Hz, J 2 = 2.0 Hz, 1H), 8.11 (dd, J 1 = 8.4 Hz, J 2 = 0.8 Hz, 1H).13C NMR (100 MHz, CDCl3) δ: 14.8, 28.9, 29.0, 51.8, 55.7, 111.2, 111.4, 111.5,117.9, 118.1, 124.7, 124.8, 125.4, 139.4, 148.5, 152.2, 162.5. HRMS calcd forC20H26FN4O: 357.2085 [M+H]+, found: 357.2097。According to the method described in Example 1, 1d (0.2 mmol, 48.0 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) were added to a 25 mL reaction vial, at room temperature After stirring for 1 hour, palladium acetate (0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg) were added. The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine. water and sodium sulfate to dry. Filtration, spin-drying, and silica gel column separation (petroleum ether/ethyl acetate=20/1) gave the product 4d (51 mg, 72%) as a white solid. The characterization data of this compound are as follows: 1 H NMR (400 MHz, CDCl 3 ) δ: 1.49(s, 9H), 1.58 (s, 9H), 2.50 (s, 3H), 5.67 (s, 1H), 7.11-7.15 (m, 1H), 7.44(dd, J1 = 7.6 Hz, J2 = 2.0 Hz, 1H), 8.11 (dd, J1 = 8.4 Hz, J2 = 0.8 Hz, 1H ) . , CDCl 3 ) δ: 14.8, 28.9, 29.0, 51.8, 55.7, 111.2, 111.4, 111.5, 117.9, 118.1, 124.7, 124.8, 125.4, 139.4 , 148.5, 156 F.2, 162.5 cal H for 2 357.2085 [M+H] + , found: 357.2097.
实施例23Example 23
按实施例1所述的方法,在25 mL的反应瓶中加入1e (0.2 mmol, 48.0 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时,加入醋酸钯(0.01mmol, 2.2 mg)、醋酸铜(0.2 mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4e(50 mg, 70%)。该化合物的表征数据如下:1H NMR (400 MHz, CDCl3) δ: 1.50(s, 9H), 1.59 (s, 9H), 2.51 (s, 3H), 5.67 (s, 1H), 7.00-7.05 (m, 1H), 7.71(dd, J 1 = 8.4 Hz, J 2 = 4.8 Hz, 1H), 7.86 (dd, J 1 = 8.0 Hz, J 2 = 2.0 Hz, 1H).13C NMR (100 MHz, CDCl3) δ: 14.8, 28.8, 28.9, 51.8, 55.7, 110.5, 110.8, 112.2,115.8, 116.1, 125.23, 125.25, 125.3, 131.3, 132.3, 136.8, 147.7, 152.1,162.3, 163.6. HRMS calcd for C20H26FN4O: 357.2085 [M+H]+, found: 357.2098。According to the method described in Example 1, 1e (0.2 mmol, 48.0 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) were added to a 25 mL reaction vial. After stirring for 1 hour, palladium acetate (0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg) were added. The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine. water and sodium sulfate to dry. After filtration, spin-drying, and silica gel column separation (petroleum ether/ethyl acetate=20/1), the product 4e (50 mg, 70%) was obtained as a white solid. The characterization data of this compound are as follows: 1 H NMR (400 MHz, CDCl 3 ) δ: 1.50(s, 9H), 1.59 (s, 9H), 2.51 (s, 3H), 5.67 (s, 1H), 7.00-7.05 (m, 1H), 7.71(dd, J1 = 8.4 Hz, J2 = 4.8 Hz, 1H), 7.86 (dd, J1 = 8.0 Hz, J2 = 2.0 Hz, 1H ) . , CDCL 3 ) Δ: 14.8, 28.8, 28.9, 51.8, 55.7, 110.5, 110.8, 112.2,115.8, 116.1, 125.23, 125.3, 131.3, 136.8, 147.7, 152.162.3, 163.6. HRMS CALCD for C 20 H 26 FN 4 O: 357.2085 [M+H] + , found: 357.2098.
实施例24Example 24
按实施例1所述的方法,在25 mL的反应瓶中加入1f (0.2 mmol, 51.2 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时,加入醋酸钯(0.01mmol, 2.2 mg)、醋酸铜(0.2 mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4f(57 mg, 76%)。该化合物的表征数据如下:1H NMR (400 MHz, CDCl3) δ: 1.50(s, 9H), 1.58 (s, 9H), 2.51 (s, 3H), 5.67 (s, 1H), 7.32 (dd, J 1 = 8.4 Hz, J 2 =2.0 Hz, 1H), 7.67 (d, J = 8.0 Hz, 1H), 8.13 (d, J = 1.6 Hz, 1H). 13C NMR (100MHz, CDCl3) δ: 14.8, 28.9, 29.0, 51.8, 54.5, 112.2, 123.1, 124.7, 129.2,130.7, 134.9, 137.4, 147.6, 152.3, 162.3. HRMS calcd for C20H25ClN4ONa:395.1609 [M+Na]+, found: 395.1624。According to the method described in Example 1, 1f (0.2 mmol, 51.2 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) were added to a 25 mL reaction vial. After stirring for 1 hour, palladium acetate (0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg) were added. The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine. water and sodium sulfate to dry. Filtration, spin-drying, and silica gel column separation (petroleum ether/ethyl acetate=20/1) gave the product 4f (57 mg, 76%) as a white solid. The characterization data of this compound are as follows: 1 H NMR (400 MHz, CDCl 3 ) δ: 1.50(s, 9H), 1.58 (s, 9H), 2.51 (s, 3H), 5.67 (s, 1H), 7.32 (dd , J 1 = 8.4 Hz, J 2 =2.0 Hz, 1H), 7.67 (d, J = 8.0 Hz, 1H), 8.13 (d, J = 1.6 Hz, 1H). 13 C NMR (100MHz, CDCl 3 ) δ : 14.8, 28.9, 29.0 , 51.8, 54.5, 112.2, 123.1, 124.7, 129.2,130.7 , 134.9 , 137.4, 147.6 , 152.3, 162.3. found: 395.1624.
实施例25Example 25
按实施例1所述的方法,在25 mL的反应瓶中加入1g (0.2 mmol, 58.0 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,加入醋酸钯(0.01mmol, 2.2 mg)、醋酸铜(0.2 mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4g(54 mg, 67%)。该化合物的表征数据如下:1H NMR (400 MHz, CDCl3) δ: 1.51(s, 9H), 1.60 (s, 9H), 2.53 (s, 3H), 5.67 (s, 1H), 7.63 (d, J = 8.0 Hz, 1H),7.87 (d, J = 8.8 Hz, 1H), 8.36 (s, 1H). 13C NMR (100 MHz, CDCl3) δ: 14.7,28.9, 29.1, 29.7, 51.9, 56.1, 112.5, 119.69, 119.73, 119.8, 124.0, 126.15,126.19, 130.0, 133.4, 136.6, 139.8, 147.4, 153.0, 162.2. HRMS calcd forC21H26F3N4O: 407.2053 [M+H]+, found: 407.2065。According to the method described in Example 1, add 1g (0.2 mmol, 58.0 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction vial, After stirring for 1 hour, palladium acetate (0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg) were added. The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine. water and sodium sulfate to dry. Filter, spin dry, and separate through silica gel column (petroleum ether/ethyl acetate=20/1) to obtain 4 g (54 mg, 67%) of white solid product. The characterization data of this compound are as follows: 1 H NMR (400 MHz, CDCl 3 ) δ: 1.51(s, 9H), 1.60 (s, 9H), 2.53 (s, 3H), 5.67 (s, 1H), 7.63 (d , J = 8.0 Hz, 1H), 7.87 (d, J = 8.8 Hz, 1H), 8.36 (s, 1H). 13 C NMR (100 MHz, CDCl 3 ) δ: 14.7,28.9, 29.1, 29.7, 51.9, 56.1, 112.5, 119.69 , 119.73 , 119.8, 124.0, 126.15, 126.19 , 130.0, 133.4, 136.6, 139.8, 147.4, 153.0 , 162.2 . found: 407.2065.
实施例26Example 26
按实施例1所述的方法,在25 mL的反应瓶中加入1h (0.2 mmol, 53.2 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,加入醋酸钯(0.01mmol, 2.2 mg)、醋酸铜(0.2 mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4h(66 mg, 87%)。该化合物的表征数据如下:1H NMR (400 MHz, CDCl3) δ: 1.48(s, 9H), 1.57 (s, 9H), 2.47 (s, 3H), 5.63 (s, 1H), 6.02 (s, 2H), 7.18 (s,1H), 7.62 (s, 1H). 13C NMR (100 MHz, CDCl3) δ: 14.8, 28.9, 29.0, 51.7, 55.5,101.8, 104.0, 104.7, 106.7, 110.8, 115.2, 124.2, 131.5, 148.7, 150.2, 151.7,162.7. HRMS calcd for C21H27N4O3: 383.2078 [M+H]+, found: 383.2089。According to the method described in Example 1, add 1h (0.2 mmol, 53.2 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) into a 25 mL reaction vial, room temperature After stirring for 1 hour, palladium acetate (0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg) were added. The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine. water and sodium sulfate to dry. Filter, spin dry, and separate through silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the white solid product 4h (66 mg, 87%). The characterization data of this compound are as follows: 1 H NMR (400 MHz, CDCl 3 ) δ: 1.48(s, 9H), 1.57 (s, 9H), 2.47 (s, 3H), 5.63 (s, 1H), 6.02 (s , 2H), 7.18 (s,1H), 7.62 (s, 1H). 13 C NMR (100 MHz, CDCl 3 ) δ: 14.8, 28.9, 29.0, 51.7, 55.5,101.8, 104.0, 104.7, 106.7, 110.8, 115.2, 124.2, 131.5, 148.7, 150.2, 151.7, 162.7. HRMS calcd for C 21 H 27 N 4 O 3 : 383.2078 [M+H] + , found: 383.2089.
实施例27Example 27
按实施例1所述的方法,在25 mL的反应瓶中加入1i (0.2 mmol, 47.2 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,加入醋酸钯(0.01mmol, 2.2 mg)、醋酸铜(0.2 mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4i(57 mg, 81%)。该化合物的表征数据如下:1H NMR (400 MHz, CDCl3) δ: 1.37(t, J = 7.6 Hz, 3H), 1.50 (s, 9H), 1.60 (s, 9H), 2.87 (q, J = 7.2 Hz, 2H),5.72 (s, 1H), 7.34-7.38 (m, 1H), 7.43-7.47 (m, 1H), 7.77 (d, J = 8.0 Hz, 1H),7.97 (d, J = 8.4 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ: 12.6, 22.2, 28.9, 29.0,51.8, 55.6, 111.1, 122.1, 123.7, 129.2, 129.4, 131.3, 136.9, 137.9, 147.9,158.3, 162.8. HRMS calcd for C21H29N4O: 353.2336 [M+H]+, found: 353.2349。According to the method described in Example 1, 1i (0.2 mmol, 47.2 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) were added to a 25 mL reaction vial, at room temperature After stirring for 1 hour, palladium acetate (0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg) were added. The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine. water and sodium sulfate to dry. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4i (57 mg, 81%) as a white solid. The characterization data of this compound are as follows: 1 H NMR (400 MHz, CDCl 3 ) δ: 1.37(t, J = 7.6 Hz, 3H), 1.50 (s, 9H), 1.60 (s, 9H), 2.87 (q, J = 7.2 Hz, 2H),5.72 (s, 1H), 7.34-7.38 (m, 1H), 7.43-7.47 (m, 1H), 7.77 (d, J = 8.0 Hz, 1H),7.97 (d, J = 8.4 Hz, 1H). 13 C NMR (100 MHz, CDCl 3 ) δ: 12.6, 22.2, 28.9, 29.0,51.8, 55.6, 111.1, 122.1, 123.7, 129.2, 129.4, 131.3, 158.9, 1347.9, 162.8. HRMS calcd for C 21 H 29 N 4 O: 353.2336 [M+H] + , found: 353.2349.
实施例28Example 28
按实施例1所述的方法,在25 mL的反应瓶中加入1j (0.2 mmol, 50.0 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,加入醋酸钯(0.01mmol, 2.2 mg)、醋酸铜(0.2 mmol, 36.2 mg)、叔丁基异腈(3a, 0.44 mmol, 36.5 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得白色固体产物4j(61 mg, 83%)。该化合物的表征数据如下:1H NMR (400 MHz, CDCl3) δ: 1.02-1.06 (m, 3H), 1.50 (s, 9H), 1.60 (s, 9H), 1.79-1.82 (m, 2H), 2.81 (t, J = 6.8Hz, 2H), 5.71 (s, 1H), 7.36 (t, J = 7.2 Hz, 1H), 7.45 (t, J = 7.2 Hz, 1H),7.76 (d, J = 8.0 Hz, 1H), 7.97 (d, J = 8.0 Hz, 1H). 13C NMR (100 MHz, CDCl3)δ: 13.9, 21.7, 29.0, 29.1, 30.5, 51.8, 55.7, 111.3, 122.1, 123.7, 129.2,129.4, 131.3, 136.9, 137.9, 147.8, 157.0, 162.8. HRMS calcd for C22H31N4O:367.2492 [M+H] +, found: 367.2487。According to the method described in Example 1, 1j (0.2 mmol, 50.0 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) were added to a 25 mL reaction vial, at room temperature After stirring for 1 hour, palladium acetate (0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), tert-butylisonitrile (3a, 0.44 mmol, 36.5 mg) and potassium carbonate (0.4 mmol, 55.2 mg) were added. The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine. water and sodium sulfate to dry. It was filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the product 4j (61 mg, 83%) as a white solid. The characterization data of this compound are as follows: 1 H NMR (400 MHz, CDCl 3 ) δ: 1.02-1.06 (m, 3H), 1.50 (s, 9H), 1.60 (s, 9H), 1.79-1.82 (m, 2H) , 2.81 (t, J = 6.8Hz, 2H), 5.71 (s, 1H), 7.36 (t, J = 7.2 Hz, 1H), 7.45 (t, J = 7.2 Hz, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.97 (d, J = 8.0 Hz, 1H). 13 C NMR (100 MHz, CDCl 3 )δ: 13.9, 21.7, 29.0, 29.1, 30.5, 51.8, 55.7, 111.3, 122.1, 123.7, 129.2, 129.4, 131.3, 136.9, 137.9, 147.8, 157.0, 162.8. HRMS calcd for C 22 H 31 N 4 O: 367.2492 [M+H] + , found: 367.2487.
实施例29Example 29
按实施例1所述的方法,在25 mL的反应瓶中加入1k (0.2 mmol, 59.8 mg)、2a(0.22 mmol, 16.3 mg)及N,N-二甲基甲酰胺(1 mL),室温搅拌1小时后,加入醋酸钯(0.01mmol, 2.2 mg)、醋酸铜(0.2 mmol, 36.2 mg)、2,6-二甲基苯基异腈(3b, 0.44 mmol,57.7 mg)和碳酸钾(0.4 mmol, 55.2 mg)。所得混合物在空气气氛中于120℃搅拌反应8小时后,加入10 mL饱和氯化铵溶液淬灭反应,用乙酸乙酯萃取(6 mL × 3),之后有机相用水和饱和食盐水依次洗涤,无水硫酸钠干燥。过滤,旋干,过硅胶柱分离(石油醚/乙酸乙酯=20/1)得到目标产物4k。According to the method described in Example 1, 1k (0.2 mmol, 59.8 mg), 2a (0.22 mmol, 16.3 mg) and N,N-dimethylformamide (1 mL) were added to a 25 mL reaction vial. After stirring for 1 h, palladium acetate (0.01 mmol, 2.2 mg), copper acetate (0.2 mmol, 36.2 mg), 2,6-dimethylphenylisonitrile (3b, 0.44 mmol, 57.7 mg) and potassium carbonate ( 0.4 mmol, 55.2 mg). The resulting mixture was stirred and reacted at 120 °C in an air atmosphere for 8 hours, then quenched by adding 10 mL of saturated ammonium chloride solution, extracted with ethyl acetate (6 mL × 3), and then the organic phase was washed successively with water and saturated brine, Dry over anhydrous sodium sulfate. Filtered, spin-dried, and separated on a silica gel column (petroleum ether/ethyl acetate=20/1) to obtain the target product 4k.
以上实施例描述了本发明的基本原理、主要特征及优点,本行业的技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明原理的范围下,本发明还会有各种变化和改进,这些变化和改进均落入本发明保护的范围内。The above embodiments have described the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited by the above embodiments. What are described in the above embodiments and description are only to illustrate the principles of the present invention. Without departing from the scope of the principle of the present invention, there will be various changes and improvements in the present invention, and these changes and improvements all fall within the protection scope of the present invention.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510345086.6A CN105037369B (en) | 2015-06-23 | 2015-06-23 | A kind of synthetic method of pyrazolo [5,1 a] Carbox amide of iso-indoles 3 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510345086.6A CN105037369B (en) | 2015-06-23 | 2015-06-23 | A kind of synthetic method of pyrazolo [5,1 a] Carbox amide of iso-indoles 3 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105037369A CN105037369A (en) | 2015-11-11 |
CN105037369B true CN105037369B (en) | 2017-07-07 |
Family
ID=54444391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510345086.6A Active CN105037369B (en) | 2015-06-23 | 2015-06-23 | A kind of synthetic method of pyrazolo [5,1 a] Carbox amide of iso-indoles 3 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105037369B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07219179A (en) * | 1994-02-07 | 1995-08-18 | Fuji Photo Film Co Ltd | Silver halide photographic sensitive material |
CN1076728C (en) * | 1999-02-05 | 2001-12-26 | 浙江大学 | Derivative of 2-aryl imidazo [2,1-a] isoquinoline and its use |
EP1847543A1 (en) * | 2006-04-19 | 2007-10-24 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dihydrothienopyrimidines for the treatment of inflammatory diseases |
CN103265545B (en) * | 2013-06-07 | 2015-06-10 | 武汉大学 | Method for preparing parazole iso-indole compound |
-
2015
- 2015-06-23 CN CN201510345086.6A patent/CN105037369B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN105037369A (en) | 2015-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103408445B (en) | A kind of arylamine derivative and preparation method thereof | |
CN107973778B (en) | A kind of ruthenium catalysis aromatic ketone replaces the methods and application of naphthalene derivatives with the more virtues of tolans cyclization preparation | |
CN104926818B (en) | A kind of synthetic method of pyrazolo [5,1 a] isoindoles compound | |
CN108610278B (en) | Synthetic method of 6-amino-5-acyl benzo [ a ] carbazole compound | |
CN108640917A (en) | A kind of synthetic method of indoles simultaneously [2,1-a] isoquinoline compound | |
CN107954821A (en) | A kind of ruthenium catalysis dibenzyl ketone prepares method and the application of more virtue substitution naphthalene derivativeses with interior alkynes cyclization | |
CN107602452B (en) | A kind of synthetic method of 3-acyl pyridine compounds | |
CN104774202B (en) | A kind of synthetic method of 9H-pyrido [2,3-b] Benzazole compounds | |
CN104804002B (en) | Synthesis method for 9H-pyrimido(4,5-b) indole compounds | |
CN105037369B (en) | A kind of synthetic method of pyrazolo [5,1 a] Carbox amide of iso-indoles 3 | |
CN108314642B (en) | A kind of synthetic method of 2-methylpyridine compounds | |
CN104774172B (en) | Method for synthesizing 3-cyanoindole compound | |
CN110746319A (en) | Synthesis method of E-type benzofulvene derivative | |
CN107188792B (en) | Synthetic method of 2,4' -dihydroxy benzophenone compound | |
CN110041220A (en) | A kind of symmetrical imide analog compounds and its synthetic method | |
CN104030994A (en) | Synthetic method for 1,2,3-triazole compounds | |
CN108864173B (en) | Process for converting substituted sodium aryl sulfinate to aryl tri-n-butyl tin | |
CN108929262B (en) | Synthetic method of benzo [ a ] carbazole compound | |
CN112125817A (en) | Synthesis method of tertiary amide compound | |
CN108976198A (en) | A kind of synthetic method of 3- (4- pyridine) Benzazole compounds | |
CN108503572A (en) | A kind of synthetic method of 3- acyl pyrrolines class compound | |
CN109265422B (en) | Method for synthesizing benzopyran derivatives under palladium catalysis | |
CN106831528B (en) | A kind of synthetic method of pyrrole-3-formate compound | |
CN106083688A (en) | A kind of synthetic method of 3 methyl 1 p-toluenesulfonyl tetrahydropyrrole compound | |
CN107641085B (en) | A kind of synthetic method of benzophenone and derivative thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |